Company profile SANA
After 39 days of this quarter the interest is at 345.0. Based on that we can calculate that during remaining 52 days it will total up to 805.0. That appears to be equal to previous quarter and same quarter last year.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 558 | 719 28.9% QoQ | 632 -12.1% QoQ | 679 7.4% QoQ |
| 2020 | 886 58.8% YoY 30.5% QoQ | 723 0.6% YoY -18.4% QoQ | 711 12.5% YoY -1.7% QoQ | 585 -13.8% YoY -17.7% QoQ |
| 2021 | 760 -14.2% YoY 29.9% QoQ | 629 -13.0% YoY -17.2% QoQ | 561 -21.1% YoY -10.8% QoQ | 564 -3.6% YoY 0.5% QoQ |
| 2022 | 815 7.2% YoY 44.5% QoQ | 813 29.3% YoY -0.2% QoQ | 677 20.7% YoY -16.7% QoQ | 697 23.6% YoY 3.0% QoQ |
| 2023 | 893 9.6% YoY 28.1% QoQ | 743 -8.6% YoY -16.8% QoQ | 644 -4.9% YoY -13.3% QoQ | 752 7.9% YoY 16.8% QoQ |
| 2024 | 345 -61.4% YoY -54.1% QoQ | - | - | - |
The average 5 years interest of Biotechnology was 55.12 per week. The last year interest of Biotechnology compared to the last 5 years has changed by 3.41%. The interest for Biotechnology is seasonal. The last year interest is comparable to 5 years ago. It has changed only by 1.55%.
After 39 days of this quarter the interest is at 23.0. Based on that we can calculate that during remaining 52 days it will total up to 54.0. Sana Biotechnology expected interest is significantly lower compared to previous quarter (-64.5%) and same quarter last year (-62.5%).
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 33 | 72 118.2% QoQ | 62 -13.9% QoQ | 54 -12.9% QoQ |
| 2020 | 84 154.5% YoY 55.6% QoQ | 62 -13.9% YoY -26.2% QoQ | 46 -25.8% YoY -25.8% QoQ | 58 7.4% YoY 26.1% QoQ |
| 2021 | 327 289.3% YoY 463.8% QoQ | 138 122.6% YoY -57.8% QoQ | 118 156.5% YoY -14.5% QoQ | 95 63.8% YoY -19.5% QoQ |
| 2022 | 197 -39.8% YoY 107.4% QoQ | 157 13.8% YoY -20.3% QoQ | 139 17.8% YoY -11.5% QoQ | 138 45.3% YoY -0.7% QoQ |
| 2023 | 144 -26.9% YoY 4.3% QoQ | 99 -36.9% YoY -31.2% QoQ | 111 -20.1% YoY 12.1% QoQ | 152 10.1% YoY 36.9% QoQ |
| 2024 | 23 -84.0% YoY -84.9% QoQ | - | - | - |
The average 5 years interest of Sana Biotechnology was 8.85 per week. The last year interest of Sana Biotechnology compared to the last 5 years has changed by 1.24%. This is something to be checked. The last year interest is quite higher compared to 5 years ago. It has increased by 70.02%.
There is not enough data for engineered cells as medicines to provide analysis
There is not enough data for engineered cells as medicines to provide correlation calculation
There is not enough data for engineered cells as medicines to provide analysis
There is not enough data for SG299 cancer therapy to provide analysis
There is not enough data for SG299 cancer therapy to provide correlation calculation
There is not enough data for SG299 cancer therapy to provide analysis
There is not enough data for SG242 cancer therapy to provide analysis
There is not enough data for SG242 cancer therapy to provide correlation calculation
There is not enough data for SG242 cancer therapy to provide analysis
There is not enough data for SG221 multiple myeloma treatment to provide analysis
There is not enough data for SG221 multiple myeloma treatment to provide correlation calculation
There is not enough data for SG221 multiple myeloma treatment to provide analysis
There is not enough data for SG239 multiple myeloma treatment to provide analysis
There is not enough data for SG239 multiple myeloma treatment to provide correlation calculation
There is not enough data for SG239 multiple myeloma treatment to provide analysis
There is not enough data for SG233 NHL therapy to provide analysis
There is not enough data for SG233 NHL therapy to provide correlation calculation
There is not enough data for SG233 NHL therapy to provide analysis
There is not enough data for SG418 sickle cell disease to provide analysis
There is not enough data for SG418 sickle cell disease to provide correlation calculation
There is not enough data for SG418 sickle cell disease to provide analysis
There is not enough data for SC291 allogeneic T cell therapy to provide analysis
There is not enough data for SC291 allogeneic T cell therapy to provide correlation calculation
There is not enough data for SC291 allogeneic T cell therapy to provide analysis